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Abstract: 
We design a “simple” and “low cost” model technology for monitoring HIV viral load in resource-poor settings: 
SMARThivVLmos. Cost and complexity are the major challenges to the developing world, in monitoring HIV patients viral load. 
We have previously demonstrated in our SMARThivPack model that cost and complexity of laboratory monitoring of HIV 
patients, may be reduced not only at a first technology development level, but also at a second technology implementation, and at 
a third global coordination levels. In our SMARThivPack model, the P24 HIV viral load monitoring system passed both the 
“cost” and the “complexity” tests. However, compared to other alternative viral monitoring systems such as the Cavidi EXAVIR, 
the sensitivity of the P24 system is too low. Here we describe a dynamic model technology that overcomes the sensitivity barrier 
of the P24 system while maintaining simplicity and low cost.  
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Background: 
In the clinical management of HIV patients; CD4 count is 
used to determine when to start AntiRetroViral (ARV) 
treatment, and viral load data are used to monitor whether 
ARV treatment is successful. Viral load testing is routinely 
performed in the developed world. However, viral load 
monitoring was not recommended in the World Health 
Organisation (WHO) 2003 HIV patients treatment guidelines 
for resource-poor settings. [1, 2] In the developing world, 
equipments to perform viral load measurement are often 
unavailable, and where available the high cost of kits limited 
viral load testing in resource-poor settings.[2] Expert panels 
therefore recommended cheaper and simpler so called 
alternative technologies for viral load testing in resource-poor 
settings.[3, 4]  
 
We have previously proposed a “three tests” combo kit model 
for monitoring HIV patients in resource-poor settings: 
SMARThivPack. [3] Our SMARThivPack model retained the 
alternative P24 HIV viral load monitoring system. The p24 
system is both cheap and simple. The drawback of the p24 
system is its low sensitivity. While the alternative Cavidi 
EXAVIR viral load testing system can detect down to 500 
copies/ml of viral load, the cut-off value of the P24 system is 
30.000 copies/ml. [4] However, incorporation of the Cavidi 
EXAVIR in our SMARThivPack model would raise 
equipment cost, because the system relied on different 
equipments than the ones used to perform CD4 count and 
pharmacoresistance testing. [3] Here we describe a dynamic 
model technology to improve the sensitivity, while 
maintaining simplicity and low cost, in monitoring HIV viral 
load in resource-poor settings.    
 
Description: 
We used web-based data mining and detailed investigation of 
existing viral load monitoring protocols, to design a model 
technology for monitoring HIV viral load in resource-poor 
settings. Using our cost and complexity level standards for 
guidance, we aim to design an HIV load measurement system 
that is compatible with our SMARThivPack model. [3] Our 
cost standard favours “low cost” over “high cost”, and our 
complexity level standard favours “user friendly” 
“automated” text execution, over “manual” test execution. 
Our SMARThivPack model favours specialisation to a limited 
number of technologies, over technology and skill diversity.  
 
In designing our dynamic SMARThivVLmos model, we 
hypothesize that the reliance of the P24 viral load 
measurement system (“P24 system”) on ELISA plate reader 
makes the system compatible with our SMARThivPack 
model, and that the lower sensitivity of the P24 system may 
be overcome within our SMARThivPack model without 
further investment neither in equipment cost nor in training 
cost. Furthermore, compared to a single “static” technology 
system, the dynamic nature of our SMARThivVLmos 
expands the possibility of protocol choice for HIV viral load 
measurement, on case by case basis. 
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In SMARThivVLmos, the P24 system passed the cost and 
complexity tests using ELISA plate reader as essential 
equipment. SMARThivVLmos overcomes the sensitivity 
barrier of the P24 system by incorporating a PCR-based viral 
load measurement system. 
 
The P24 system passed the “cost” test in our SMARThivPack 
model with a total equipment cost of $ 0 USD. Cost of the 
essential ELISA plate reader was applied toward the CD4 
counting CAPCELLIA technology. [3] The p24 system also 
passed the “complexity level” test in our SMARThivPack 
model. ELISA is a simple technology that does not require 
long term training and viral load measurement is 
“automatically” performed by the ELISA plate reader. [3] 
 
The drawback of the “simple” and “low cost” p24 system is 
its “low sensitivity”. The cut off value of the p24 system is 
30.000 copies/ml. Using the manufacturer provided reagents 
the p24 system can detect viral copies when the per/ml plasma 
viral content is 30.000 copies or above. [4, 5, 6], (Figure 1a) 
The Cavidi EXAVIR, an HIV viral load monitoring system 
recommended for resource-poor settings, has a cut off value 
of 500copies/ml. [7] Our SMARThivPack model did not 
retain the Cavidi Exavir technology because incorporation of 
the Cavidi EXAVIR system would raise both equipment cost 
and complexity, by adding the requirements of different 
equipments and skills. [3, 7] Therefore, based on our 
standard, the Cavidi EXAVIR systems failed both the cost test 
and the complexity level test. A technology must overcome 
both cost and complexity factors to be successful in resource-
poor and low expertise countries. However, the failure of a 
given technology to qualify within one “three tests” combo kit 
pack model does not necessarily mean that the same 
technology may not qualify within another pack model. 
Components of the Biotech tropicana, Inc SMARThivPack 
are dynamic structures. [3]  
 
 
Figure 1: SMARThivVLmos: A conceptual framework. SMARThivVLmos is a dynamic HIV viral load monitoring model 
technology that comports three (c) protocols. Using the manufacturer provided reagents; the sensitivity of the P24 is satisfactory 
at 30.000 copies/ml or above (a). Using external reagent the sensitivity may be improved down to 5.000 copies/ml. (b) Our model 
incorporated a “modified PCR-based” protocol for viral load values below 5.000 copies/ml. (c) Our SMARThivGLOBALmos 
system (under construction) incorporates at least one (a) control standard laboratory in reference centres, (Standard VL Lab 
Protocol) in addition to the alternative SMARThivPack laboratories in peripheral centres. We had a special info basket for 
recording special issues encountered while using the system and for recording improvements in the investigational areas. (d)  Bioinformation by Biomedical Informatics Publishing Group     open access 
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The sensitivity of the P24 system may be improved using 
reagents other than the ones provided by the manufacturer. It 
has been reported that using an external buffer for sample 
preparation, the sensitivity of the p24 system may be 
improved to 5000 copies/ml. [4, 8]; (Figure 1b) However, 
compared to the 500 copies/ml using the Cavidi system, the 
5000 copies/ml using the P24 is still low. 
 
To maintain “simplicity” and “low cost” while improving 
“sensitivity” we add one (1) additional protocol to our 
SMARThivVL system. Hamatake et al. reported a 
competitive PCR-based “simple” and “low cost” viral load 
system. [9] PCR-based viral load systems are generally ultra 
sensitive. [10] The PCR-based viral load system developed by 
Hamatake et al; can detect down to 110 copies/ml. [9] Our 
SMARThivPack model comports a PCR system for 
monitoring HIV drug resistance in resource-poor settings. [3] 
Because we applied the cost of the PCR equipments toward 
the drug resistance monitoring system, we can add a PCR-
based viral load protocol without violating our “cost” 
standard. Because our SMARThivPack model comports a 
“PCR team” for performing HIV drug resistance, the addition 
of the modified-PCR protocol in our SMARThivVLmos 
system does not require a new skill, consistent with our skill 
diversity avoidance criteria. [3] (Figure 1c) 
 
The drawbacks of the PCR-based systems are their “high 
cost” and “high complexity” [3, 4, 10] Most of these pcr-
based systems failed both our cost and complexity tests, for 
the developing world. Our “cost” standard favour “low cost” 
over “high cost”, and our “complexity level” standard favours 
“simple, user friendly” “automated” technologies over 
technologies that are “complex” and/or requires substantial 
human input. [3] 
 
The Biotech tropicana, Inc SMARThivVLmos is a dynamic 
structure of the Biotech tropicana, Inc SMARThivPack model 
for improving HIV patients monitoring standards in resource-
poor settings. Our SMARThivVLmos system combines “low 
cost” and “simplicity” of the ELISA technology with “high 
sensitivity” of the PCR-based viral load systems. The 
flexibility of our SMARThivVLmos system permits choice 
between three protocols, on case by case basis. The Biotech 
tropicana, Inc SMARThivVLmos is an intended component 
of the Biotech tropicana, Inc SMARThivPack. A detailed 
protocol for test execution using the SMARThivVLmos 
technology is under development at Biotech tropicana, Inc.  
The Biotech tropicana, Inc SMARThivPack is an intended 
component of the Biotech tropicana, Inc “life Box”, 
comporting in addition to the “three tests” combo kit, an 
ELISA plate reader and a PCR set up.  The Biotech tropicana, 
Inc “Life Box” is an intended component of the Biotech 
tropicana, Inc SMARThivGLOBALmos, a third level global 
coordination cost and complexity reductions model, 
comporting in addition to the SMARThivPack-based “Life 
Box”, alternative “Life Boxes” (“A-Life Box”). Choosing 
from the pool of available alternatives technologies 
recommended for the developing world, Biotech tropicana, 
Inc is in the process of constructing alternative hivPack 
models (“A-Life Box”), for incorporation into the Biotech 
tropicana, Inc the SMARThivGLOBALmos. The Biotech 
tropicana, Inc “A-life Boxes” are dynamic structures, 
constructed on case by case basis, based on existing 
equipments and skills in a given laboratory, to overcome cost 
and complexity.  
We design a dynamic model technology by combining the 
“simplicity” and “low cost” of the ELISA technology and the 
“high sensitivity” of a PCR-based HIV viral load monitoring 
system: SMARThivVLmos. Our dynamic SMARThivVLmos 
system is flexible enough to, permit protocol choice on case 
by case basis, for optimal cost/sensitivity ratio.  
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